Australia markets open in 7 hours 24 minutes

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
9,951.00-7.00 (-0.07%)
At close: 04:21PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 154.08B
Enterprise value 176.15B
Trailing P/E N/A
Forward P/E 14.16
PEG ratio (5-yr expected) 1.18
Price/sales (ttm)3.90
Price/book (mrq)4.79
Enterprise value/revenue 4.00
Enterprise value/EBITDA 24.80

Trading information

Stock price history

Beta (5Y monthly) 0.13
52-week change 313.44%
S&P500 52-week change 3-13.12%
52-week high 311,540.00
52-week low 38,090.32
50-day moving average 310,601.96
200-day moving average 39,958.92

Share statistics

Avg vol (3-month) 32.32M
Avg vol (10-day) 32.67M
Shares outstanding 51.55B
Implied shares outstanding 6N/A
Float 81.54B
% held by insiders 10.21%
% held by institutions 149.26%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.22
Forward annual dividend yield 42.23%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 30.03%
5-year average dividend yield 43.03
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 411 Aug 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 June 2022

Profitability

Profit margin -2.85%
Operating margin (ttm)17.08%

Management effectiveness

Return on assets (ttm)5.52%
Return on equity (ttm)-4.84%

Income statement

Revenue (ttm)44.04B
Revenue per share (ttm)28.67
Quarterly revenue growth (yoy)31.00%
Gross profit (ttm)27.61B
EBITDA 12.52B
Net income avi to common (ttm)-1.25B
Diluted EPS (ttm)-58.80
Quarterly earnings growth (yoy)-34.50%

Balance sheet

Total cash (mrq)4.89B
Total cash per share (mrq)3.15
Total debt (mrq)31.39B
Total debt/equity (mrq)87.31
Current ratio (mrq)0.96
Book value per share (mrq)23.20

Cash flow statement

Operating cash flow (ttm)7.62B
Levered free cash flow (ttm)3.99B